You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

Claims for Patent: 7,982,092


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,982,092
Title:Chimeric gene comprising intron from histone H3.3 gene
Abstract: An isolated DNA sequence capable of serving as regulatory element in a chimeric gene which can be used for the transformation of plants is disclosed. A chimeric gene containing the DNA sequence as a regulatory element for the transformation of plants is also disclosed. The gene comprises at least, in the direction of transcription, a promoter sequence, a transgene and a regulatory element, characterized in that the regulatory element comprises an intron from the noncoding 5\' region of a plant histone gene, allowing the expression of the protein in the zones undergoing rapid growth. The production of transgenic plants is also disclosed.
Inventor(s): Derose; Richard (Lyons, FR), Chaubet, legal reprsentative; Nicole (Strasbourg, FR), Gigot; Claude (Strasbourg, FR)
Assignee: Bayer Cropscience SA (Lyons, FR)
Application Number:11/797,078
Patent Claims:1. A method for preferentially expressing a chimeric gene in rapidly growing tissues of a transgenic plant, said method comprising transfecting plant cells with a chimeric gene comprising the first intron of the 5' non-translated region of a plant H3.3 histone gene as a regulatory element, and thereby causing the expression of said chimeric gene in rapidly growing tissues of said transgenic plant.

2. A method of making a chimeric gene comprising: obtaining a DNA molecule comprising a promoter sequence; obtaining a DNA molecule comprising an intron from the 5' non-coding region of a plant histone H3.3-like gene; obtaining a DNA molecule encoding a signal peptide sequence; obtaining a DNA molecule comprising a sequence encoding an enzyme; constructing the chimeric gene by linking the promoter sequence, the intron derived from the 5' non-coding region of a plant histone H3.3-like gene, the DNA encoding the signal peptide sequence and the sequence encoding an enzyme, optionally including one or more linker sequences.

3. The method of claim 2, wherein the sequence encoding an enzyme encodes a herbicide tolerance enzyme.

4. The method of claim 2, wherein the sequence encoding an enzyme encodes an EPSPS enzyme.

5. The method of claim 2, wherein obtaining a DNA molecule comprising an intron from the 5' non-coding region of a plant histone H3.3-like gene comprises isolating an intron from the 5' non-coding region of a gene in a plant genomic library that hybridizes under stringent conditions with a labeled histone H3.3 coding region probe.

6. The method of claim 5, wherein the plant is selected from among wheat maize or rice.

7. The method of claim 5, wherein the plant is selected from among lucerne, sunflower, soya bean, rapeseed, or Arabidopsis thaliana.

8. The method of claim 2, wherein the DNA molecule comprising an intron from the 5' non-coding region of a plant histone H3.3-like gene comprises a DNA sequence as described in SEQ ID NO: 6 or SEQ ID NO: 7.

9. A method of making a transgenic plant comprising obtaining a chimeric gene according to the method of claim 2, stably transforming plant cells with a DNA molecule comprising the chimeric gene, and growing a transgenic plant from said transformed plant cells.

10. A chimeric gene made by the method of claim 2.

11. A plant comprising as a transgene a chimeric gene made by the method of claim 2.

12. A chimeric gene comprising a promoter, an intron derived from the 5' non-translated region of a plant H3.3 histone gene, and a coding sequence.

Details for Patent 7,982,092

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 06/04/1986 ⤷  Try a Trial 2015-07-19
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 ⤷  Try a Trial 2015-07-19
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b Injection 103132 ⤷  Try a Trial 2015-07-19
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.